These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 18188178

  • 1. Looking beyond Lucentis on the management of macular degeneration.
    Fletcher EC, Chong NV.
    Eye (Lond); 2008 Jun; 22(6):742-50. PubMed ID: 18188178
    [Abstract] [Full Text] [Related]

  • 2. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A.
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy for age-related macular degeneration.
    Patel S.
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [Abstract] [Full Text] [Related]

  • 4. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience].
    Wykrota H, Gierek-Lapińska A, Trzciakowski K, Gajdzik-Gajdecka U.
    Klin Oczna; 2007 Jun; 109(10-12):402-9. PubMed ID: 18488382
    [Abstract] [Full Text] [Related]

  • 5. Age-related macular degeneration: diagnosis and management.
    Cook HL, Patel PJ, Tufail A.
    Br Med Bull; 2008 Jun; 85():127-49. PubMed ID: 18334518
    [Abstract] [Full Text] [Related]

  • 6. The complement system and age-related macular degeneration.
    Sivaprasad S, Chong NV.
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J, Ruiz-Moreno JM, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, Egido J.
    Surv Ophthalmol; 2009 Aug; 54(3):339-48. PubMed ID: 19422962
    [Abstract] [Full Text] [Related]

  • 8. Age-related macular degeneration.
    Brucker AJ.
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [Abstract] [Full Text] [Related]

  • 9. Genetics of age-related macular degeneration.
    Ting AY, Lee TK, MacDonald IM.
    Curr Opin Ophthalmol; 2009 Sep; 20(5):369-76. PubMed ID: 19587596
    [Abstract] [Full Text] [Related]

  • 10. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A, Jost M, Lambert V, Lecomte J, Rakic JM.
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [Abstract] [Full Text] [Related]

  • 11. Age-related macular degeneration: a practical approach to a challenging disease.
    Bourla DH, Young TA.
    J Am Geriatr Soc; 2006 Jul; 54(7):1130-5. PubMed ID: 16866687
    [Abstract] [Full Text] [Related]

  • 12. [The role of the oxidative mechanisms in the pathogenesis of age related macular degeneration].
    Nowak M, Marek B, Kos-Kudła B, Kajdaniuk D, Głogowska-Szelag J.
    Klin Oczna; 2005 Jul; 107(7-9):537-40. PubMed ID: 16417017
    [Abstract] [Full Text] [Related]

  • 13. [The results of wet AMD treatment by intravitreal injections--preliminary report].
    Okruszko A, Borucka AI, Ulińska M, Szaflik J.
    Klin Oczna; 2007 Jul; 109(10-12):389-93. PubMed ID: 18488380
    [Abstract] [Full Text] [Related]

  • 14. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 Jul; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 15. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 16. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, Guiberteau B, Quentel G.
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [Abstract] [Full Text] [Related]

  • 17. CATT: Into the eye of a tiger.
    Sears J, Bena J, Singh AD.
    Br J Ophthalmol; 2011 Jun; 95(6):761. PubMed ID: 21602481
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.
    Boekhoorn SS, Isaacs A, Uitterlinden AG, van Duijn CM, Hofman A, de Jong PT, Vingerling JR.
    Ophthalmology; 2008 Nov; 115(11):1899-903. PubMed ID: 18708255
    [Abstract] [Full Text] [Related]

  • 20. Emerging pharmacologic therapies for wet age-related macular degeneration.
    Ni Z, Hui P.
    Ophthalmologica; 2009 Nov; 223(6):401-10. PubMed ID: 19622904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.